Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Peter Norman. (2014) Pulmonary arterial hypertension: a rare disease that encourages the development of multiple treatments. Expert Opinion on Orphan Drugs 2:11, pages 1137-1145.
Read now
Read now
Richard Kones. (2010) Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities. Vascular Health and Risk Management 6, pages 635-656.
Read now
Read now
Richard Kones. (2010) Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective. Drug Design, Development and Therapy 4, pages 383-413.
Read now
Read now
Michael J Palmer. (2009) Leads for the treatment of pulmonary hypertension. Expert Opinion on Therapeutic Patents 19:5, pages 575-592.
Read now
Read now
Niku Oksala, Mari Levula, Nina Airla, Markku Pelto-Huikko, Rebekka M. Ortiz, Otso Järvinen, Juha-Pekka Salenius, Bilge Ozsait, Evrim Komurcu-Bayrak, Nihan Erginel-Unaltuna, Ari-Pekka J. Huovila, Leena Kytömäki, Juhani T. Soini, Mika Kähönen, Pekka J. Karhunen, Reijo Laaksonen & Terho Lehtimäki. (2009) ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries—Tampere vascular study. Annals of Medicine 41:4, pages 279-290.
Read now
Read now
Gabriele Valentini & Marco Matucci Cerinic. (2008) Anti-inflammatory New trends in the treatment of the patient with systemic sclerosis. Expert Opinion on Emerging Drugs 13:2, pages 227-236.
Read now
Read now